Unified Patent Court (UPC) analytics are now available. Check here

TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Enzyme Processing, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Enzyme Processing technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Enzyme Processing

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Enzyme Processing industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Enzyme Processing industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Enzyme Processing industry

EP3031921Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation And Therapeutic ApplicationsPRESIDENT AND FELLOWS OF HARVARD COLLEGEMar 12, 2025VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
EP4032979Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionUNIQURE BIOPHARMAJan 31, 2025PFIZER
EP3227447Guide Rna With Chemical ModificationsAGILENTJan 24, 2025KRAUS & LEDERER PARTGMBB
EP3227447Guide Rna With Chemical ModificationsAGILENTJan 22, 2025DORRIES
EP4069368Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYJan 15, 2025DORRIES
EP3227447Guide Rna With Chemical ModificationsAGILENTJan 14, 2025WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB
EP3184632Hyperactive Piggybac TransposasesTRANSPOSAGEN BIOPHARMACEUTICALSJan 2, 2025HGF
EP3723506Granulate Comprising An Enzyme, A Carrier And A Vegetable OilDSM ASSETSJan 2, 2025N&H DENMARK APS
EP3723506Granulate Comprising An Enzyme, A Carrier And A Vegetable OilDSM ASSETSDec 20, 2024BASF
EP3460063Methods And Compositions For The Targeted Modification Of A GenomeREGENERON PHARMACEUTICALSDec 12, 2024WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB

To stay ahead in the competitive Enzyme Processing industry, companies are constantly innovating. Here are the top patents facing oppositions in the Enzyme Processing industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP3138910Sep 20, 2017Crispr-Based Genome Modification And RegulationSIGMA ALDRICH10
EP2791160Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA THERAPEUTICS10
EP3138911Dec 5, 2018Crispr-Based Genome Modification And RegulationSIGMA ALDRICH9
EP3360964Oct 2, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH8
EP2928496Oct 9, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH8
EP3363902Nov 27, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH7
EP3138912Dec 5, 2018Crispr-Based Genome Modification And RegulationSIGMA ALDRICH6
EP2912175Aug 22, 2018Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use ThereofTOOLGEN INCORPORATED6
EP3768304Oct 12, 2022Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing ImmunoglobulinsUNIVERSIT DE PARIS6
EP2337849Jun 13, 2018Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionSIMIONI5